Comparison of independent and combined metabolic effects of chronic treatment with ( <scp>pGlu</scp> ‐Gln)‐ <scp>CCK</scp> ‐8 and long‐acting <scp>GLP</scp> ‐1 and <scp>GIP</scp> mimetics in high fat‐fed mice

Abstract

This study highlights the potential of (pGlu-Gln)-CCK-8 alone and in combination with incretin hormones for the treatment of type 2 diabetes.